Also trades as: COPN.SW (SIX) · $vol 3M
CMOPF OTC
Cosmo Pharmaceuticals N.V.
1W: -9.8%
1M: -8.6%
3M: -24.6%
YTD: -54.6%
1Y: -22.4%
3Y: +60.0%
5Y: -20.8%
$63.10
-2.40 (-3.66%)
Weekly Expected Move ±7.0%
$54
$59
$63
$68
$72
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$612M
-5.4% ▼
5Y CAGR: +0.5%
Total Liabilities
$123M
-13.0% ▼
5Y CAGR: -8.9%
Shareholders Equity
$482M
-3.3% ▼
5Y CAGR: +3.8%
Cash & Investments
$123M
-14.2% ▼
5Y CAGR: -10.4%
Total Debt
$4M
+93.6% ▲
5Y CAGR: -52.1%
Net Debt
-$52M
-22.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $199M | $186M | $50M | $44M | $56M |
| Short-Term Investments | $24M | $55M | $0 | $99M | $67M |
| Cash & ST Investments | $222M | $241M | $50M | $143M | $123M |
| Net Receivables | $24M | $39M | $28M | $19M | $26M |
| Inventory | $13M | $11M | $14M | $14M | $10M |
| Other Current Assets | $14M | $12M | $6M | $3M | $0 |
| Total Current Assets | $276M | $306M | $102M | $202M | $183M |
| Property, Plant & Equip. | $30M | $30M | $29M | $29M | $31M |
| Goodwill & Intangibles | $397M | $391M | $380M | $356M | $350M |
| Long-Term Investments | $25M | -$47M | $3M | -$67M | $17M |
| Other Non-Current Assets | $58M | $65M | $40M | $108M | $11M |
| Total Non-Current Assets | $530M | $453M | $452M | $445M | $429M |
| Total Assets | $806M | $760M | $554M | $647M | $612M |
| — Liabilities — | |||||
| Accounts Payable | $4M | $8M | $9M | $9M | $11M |
| Short-Term Debt | $133K | $171M | $137K | $139K | $708K |
| Deferred Revenue | $6M | $0 | $9M | $0 | $0 |
| Other Current Liabilities | $1M | $10M | $109K | $17M | $13M |
| Total Current Liabilities | $21M | $195M | $26M | $48M | $25M |
| Long-Term Debt | $167M | $559K | $422K | $282K | $143K |
| Other Non-Current Liab. | $3M | $2M | $4M | $1M | $1M |
| Total Non-Current Liabilities | $272M | $101M | $99M | $93M | $98M |
| Total Liabilities | $293M | $296M | $125M | $142M | $123M |
| — Equity — | |||||
| Common Stock | $5M | $5M | $5M | $5M | $5M |
| Retained Earnings | $293M | $255M | $297M | $323M | $316M |
| Accumulated OCI | -$18M | -$11M | -$21M | $0 | $10M |
| Total Stockholders Equity | $505M | $457M | $422M | $498M | $482M |
| Total Liabilities & Equity | $806M | $760M | $554M | $647M | $612M |
| — Key Metrics — | |||||
| Total Debt | $170M | $174M | $2M | $2M | $4M |
| Net Debt | -$29M | -$12M | -$48M | -$42M | -$52M |
| Total Investments | $49M | $8M | $3M | $32M | $84M |